These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? Wu GX, Nelson RA, Kim JY, Raz DJ. Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093 [Abstract] [Full Text] [Related]
24. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program. Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P. Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745 [Abstract] [Full Text] [Related]
26. Second Primary Malignancy in Anal Carcinoma--A US Population-based Study. Shah BK, Budhathoki N. Anticancer Res; 2015 Jul; 35(7):4131-4. PubMed ID: 26124366 [Abstract] [Full Text] [Related]
27. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma. Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H. Cancer; 1995 May 01; 75(9):2281-5. PubMed ID: 7712437 [Abstract] [Full Text] [Related]
28. Thyroid adenomas after solid cancer in childhood. Haddy N, El-Fayech C, Guibout C, Adjadj E, Thomas-Teinturier C, Oberlin O, Veres C, Pacquement H, Jackson A, Munzer M, N'Guyen TD, Bondiau PY, Berchery D, Laprie A, Bridier A, Lefkopoulos D, Schlumberger M, Rubino C, Diallo I, de Vathaire F. Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):e209-15. PubMed ID: 22672756 [Abstract] [Full Text] [Related]
29. Pattern of second primary malignancies in thyroid cancer patients. Okere PC, Olusina DB, Shamim SA, Shandra V, Tushar M, Sellam K, Bal C. Niger J Clin Pract; 2013 Oct 01; 16(1):96-9. PubMed ID: 23377480 [Abstract] [Full Text] [Related]
34. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role? Silva-Vieira M, Carrilho Vaz S, Esteves S, Ferreira TC, Limbert E, Salgado L, Leite V. Thyroid; 2017 Aug 01; 27(8):1068-1076. PubMed ID: 28614983 [Abstract] [Full Text] [Related]
35. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Zhu G, Chen Y, Zhu Z, Lu L, Bi X, Deng Q, Chen X, Su H, Liu Y, Guo H, Zheng T, Yu H, Zhang Y. Dis Esophagus; 2012 Aug 01; 25(6):505-11. PubMed ID: 22067063 [Abstract] [Full Text] [Related]
36. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study. Kurlander DE, Martires KJ, Chen Y, Barnholtz-Sloan JS, Bordeaux JS. J Am Acad Dermatol; 2013 May 01; 68(5):790-6. PubMed ID: 23261548 [Abstract] [Full Text] [Related]
37. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Cancer; 2011 Oct 01; 117(19):4439-46. PubMed ID: 21432843 [Abstract] [Full Text] [Related]
39. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL. J Am Acad Dermatol; 2011 Nov 01; 65(5 Suppl 1):S69-77. PubMed ID: 22018070 [Abstract] [Full Text] [Related]